| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | SGHC | Guernsey | $9.89 | $2,342,912,011.00 | Strong Buy | 8 | N/A |
#2 | ASIC | United States | $17.20 | $405,657,000.00 | Strong Buy | 4 | 2025 |
#3 | HGTY | United States | $12.48 | $1,360,017,000.00 | Buy | 6 | N/A |
#4 | AAL | United States | $13.54 | $54,294,000,000.00 | Buy | 16 | N/A |
#5 | SRAD | Switzerland | $18.56 | $1,440,977,356.00 | Strong Buy | 18 | 2021 |
#6 | OWL | United States | $14.51 | $2,745,943,000.00 | Buy | 15 | N/A |
#7 | DCBO | Canada | $18.45 | $236,691,000.00 | Buy | 9 | 2020 |
#8 | LOCO | United States | $10.36 | $480,815,000.00 | Buy | 4 | 2014 |
#9 | EFC | United States | $13.40 | $329,815,000.00 | Strong Buy | 7 | 2010 |
#10 | SMWB | Israel | $5.72 | $275,429,000.00 | Strong Buy | 7 | 2021 |
#11 | CYRX | United States | $9.87 | $243,795,000.00 | Strong Buy | 9 | N/A |
#12 | AIP | United States | $16.16 | $65,931,000.00 | Strong Buy | 5 | 2021 |
#13 | MCS | United States | $14.94 | $712,239,000.00 | Strong Buy | 4 | N/A |
#14 | SLN | United Kingdom | $5.08 | $25,830,000.00 | Buy | 6 | N/A |
#15 | DNUT | United States | $3.19 | $1,534,272,000.00 | Buy | 6 | 2021 |
#16 | LYFT | United States | $17.34 | $6,273,827,000.00 | Buy | 31 | 2019 |
#17 | CNNE | United States | $14.43 | $430,200,000.00 | Buy | 4 | N/A |
#18 | PCRX | United States | $19.91 | $716,791,000.00 | Strong Buy | 6 | 2011 |
#19 | FTCI | United States | $10.86 | $80,028,000.00 | Buy | 4 | 2021 |
#20 | MLCO | Hong Kong | $6.34 | $5,061,044,000.00 | Buy | 6 | 2006 |
#21 | NABL | United States | $6.51 | $497,665,000.00 | Buy | 5 | N/A |
#22 | PHAT | United States | $14.01 | $147,190,000.00 | Strong Buy | 6 | 2019 |
#23 | SDGR | United States | $14.86 | $256,951,000.00 | Buy | 9 | 2020 |
#24 | TIL | United States | $7.12 | $0.00 | Buy | 4 | 2021 |
#25 | MBLY | Israel | $9.73 | $1,894,000,000.00 | Buy | 19 | 2022 |
#26 | MAX | United States | $10.54 | $1,123,093,000.00 | Buy | 6 | 2020 |
#27 | ATEC | United States | $15.31 | $728,020,000.00 | Strong Buy | 11 | 2006 |
#28 | AVPT | United States | $12.46 | $393,993,000.00 | Buy | 9 | N/A |
#29 | ENTA | United States | $12.72 | $65,324,000.00 | Strong Buy | 5 | 2013 |
#30 | CRSR | United States | $5.26 | $1,449,248,000.00 | Buy | 8 | 2020 |
#31 | KROS | United States | $18.09 | $246,718,000.00 | Buy | 9 | 2020 |
#32 | CRVO | United States | $5.64 | $6,159,786.00 | Strong Buy | 7 | N/A |
#33 | EVH | United States | $3.38 | $2,054,052,000.00 | Strong Buy | 12 | 2015 |
#34 | VERI | United States | $3.78 | $98,027,000.00 | Strong Buy | 5 | 2017 |
#35 | VSTM | United States | $6.28 | $13,379,000.00 | Strong Buy | 9 | 2012 |
#36 | LXEO | United States | $7.40 | $0.00 | Strong Buy | 10 | 2023 |
#37 | COUR | United States | $6.23 | $739,774,000.00 | Buy | 12 | 2021 |
#38 | TDOC | United States | $5.84 | $2,528,199,000.00 | Buy | 14 | 2015 |
#39 | AUPH | Canada | $14.45 | $265,808,000.00 | Buy | 4 | 1999 |
#40 | QNST | United States | $14.13 | $1,100,345,000.00 | Buy | 4 | 2010 |
#41 | COYA | United States | $4.55 | $3,987,706.00 | Strong Buy | 5 | 2022 |
#42 | SGHT | United States | $6.04 | $76,052,000.00 | Buy | 8 | 2021 |
#43 | REAL | United States | $15.29 | $662,789,000.00 | Buy | 8 | 2019 |
#44 | TSHA | United States | $4.57 | $6,310,000.00 | Strong Buy | 9 | 2020 |
#45 | AVTX | United States | $14.97 | $192,000.00 | Strong Buy | 9 | 2015 |
#46 | GBTG | United States | $6.95 | $2,517,000,000.00 | Strong Buy | 4 | N/A |
#47 | LMRI | United States | $13.31 | $1,003,375,000.00 | Strong Buy | 4 | 2025 |
#48 | PUBM | United States | $7.56 | $288,382,000.00 | Buy | 10 | 2020 |
#49 | BBNX | United States | $14.61 | $88,570,000.00 | Strong Buy | 12 | 2025 |
#50 | OFIX | United States | $13.16 | $818,058,000.00 | Buy | 6 | N/A |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (January 28, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.